Louise Davies1, H Gilbert Welch. 1. VA Outcomes Group, Department of Veterans Affairs Medical Center, White River Junction, VT 05009, USA. Louise.Davies@dartmouth.edu
Abstract
BACKGROUND: Cancer rates of the head and neck are traditionally linked to public health issues. OBJECTIVE: To describe the epidemiology of head and neck cancer in the United States. DESIGN AND SETTING: National Cancer Institute's Surveillance Epidemiology and End Results (SEER) program. RESULTS: A total of 75,000 cases of head and neck cancer were diagnosed in 2001. Incidence is rising in thyroid (up 52%), bone (43%) soft tissues (20%), salivary (20%), tongue (16%), tonsil (12%), and nose (12%). Incidence is falling in lip (down 58%), hypopharynx (35%), cervical esophagus (32%), oropharyngeal mucosa (26%), and larynx (26%). There were 30,000 deaths from head and neck cancer in 2001. Mortality has decreased to some degree at all sites except thyroid where it was stable. CONCLUSION: Many head and neck cancers have changing incidence and mortality rates contrary to expected changes given trends in public health issues. Further investigation of risk factors, diagnostic practices, and management strategies is warranted. EBM RATING: 2C.
BACKGROUND:Cancer rates of the head and neck are traditionally linked to public health issues. OBJECTIVE: To describe the epidemiology of head and neck cancer in the United States. DESIGN AND SETTING: National Cancer Institute's Surveillance Epidemiology and End Results (SEER) program. RESULTS: A total of 75,000 cases of head and neck cancer were diagnosed in 2001. Incidence is rising in thyroid (up 52%), bone (43%) soft tissues (20%), salivary (20%), tongue (16%), tonsil (12%), and nose (12%). Incidence is falling in lip (down 58%), hypopharynx (35%), cervical esophagus (32%), oropharyngeal mucosa (26%), and larynx (26%). There were 30,000 deaths from head and neck cancer in 2001. Mortality has decreased to some degree at all sites except thyroid where it was stable. CONCLUSION: Many head and neck cancers have changing incidence and mortality rates contrary to expected changes given trends in public health issues. Further investigation of risk factors, diagnostic practices, and management strategies is warranted. EBM RATING: 2C.
Authors: Moustafa Mourad; Thomas Jetmore; Ameya A Jategaonkar; Sami Moubayed; Erin Moshier; Mark L Urken Journal: J Oral Maxillofac Surg Date: 2017-05-22 Impact factor: 1.895
Authors: Orlando Guntinas-Lichius; Thomas Wendt; Jens Buentzel; Dirk Esser; Peter Lochner; Andreas Mueller; Stefan Schultze-Mosgau; Annelore Altendorf-Hofmann Journal: J Cancer Res Clin Oncol Date: 2010-01 Impact factor: 4.553
Authors: Amade Bregy; Jaims Lim; Robert Lohman; John Kane; Dheerendra Prasad; Jingxin Qiu; Robert A Fenstermaker Journal: Indian J Surg Oncol Date: 2020-07-01
Authors: Kristy A Warner; Marta Miyazawa; Mabel M R Cordeiro; William J Love; Matthew S Pinsky; Kathleen G Neiva; Aaron C Spalding; Jacques E Nör Journal: Neoplasia Date: 2008-02 Impact factor: 5.715